GAMCO Investors’s NeoGenomics NEO Stock Holding History

GAMCO Investors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$742K	Buy	100,000 +84,000	+525%	+$884K	0.01%	678
2025 Q4	$188K	Hold	16,000	–	–	﹤0.01%	1007
2025 Q3	$124K	Buy	16,000 +5,000	+45%	+$35K	﹤0.01%	1006
2025 Q2	$80.4K	Buy	+11,000	New	+$88.8K	﹤0.01%	1035
2022 Q3	–	Sell	-30,510	Closed	-$249K	–	912
2022 Q2	$249K	Sell	30,510 -700	-2%	-$6.68K	﹤0.01%	802
2022 Q1	$379K	Buy	31,210 +1,700	+6%	+$35.8K	﹤0.01%	762
2021 Q4	$1.01M	Sell	29,510 -800	-3%	-$31.3K	0.01%	624
2021 Q3	$1.46M	Sell	30,310 -100	-0.3%	-$4.63K	0.01%	562
2021 Q2	$1.37M	Buy	30,410 +2,200	+8%	+$97.5K	0.01%	587
2021 Q1	$1.36M	Sell	28,210 -13,040	-32%	-$679K	0.01%	573
2020 Q4	$2.22M	Sell	41,250 -6,100	-13%	-$276K	0.02%	464
2020 Q3	$1.75M	Sell	47,350 -11,000	-19%	-$409K	0.02%	482
2020 Q2	$1.81M	Sell	58,350 -15,840	-21%	-$439K	0.02%	471
2020 Q1	$2.05M	Sell	74,190 -24,546	-25%	-$735K	0.02%	420
2019 Q4	$2.89M	Sell	98,736 -7,700	-7%	-$183K	0.02%	440
2019 Q3	$2.04M	Sell	106,436 -25,299	-19%	-$593K	0.02%	487
2019 Q2	$2.89M	Sell	131,735 -11,700	-8%	-$257K	0.02%	447
2019 Q1	$2.94M	Sell	143,435 -7,800	-5%	-$136K	0.02%	433
2018 Q4	$1.91M	Sell	151,235 -39,284	-21%	-$585K	0.02%	466
2018 Q3	$2.92M	Sell	190,519 -5,000	-3%	-$69.1K	0.02%	437
2018 Q2	$2.56M	Sell	195,519 -146,860	-43%	-$1.62M	0.02%	453
2018 Q1	$2.79M	Buy	342,379 +233,479	+214%	+$1.89M	0.02%	426
2017 Q4	$965K	Buy	108,900 +50,000	+85%	+$461K	0.01%	578
2017 Q3	$656K	Sell	58,900 -40,800	-41%	-$397K	﹤0.01%	641
2017 Q2	$893K	Buy	99,700 +22,700	+29%	+$180K	0.01%	597
2017 Q1	$608K	Buy	77,000 +10,000	+15%	+$81.5K	﹤0.01%	650
2016 Q4	$574K	Buy	67,000 +17,000	+34%	+$146K	﹤0.01%	661
2016 Q3	$411K	Hold	50,000	–	–	﹤0.01%	692
2016 Q2	$402K	Sell	50,000 -40,000	-44%	-$321K	﹤0.01%	706
2016 Q1	$607K	Buy	90,000 +10,000	+13%	+$65.8K	﹤0.01%	647
2015 Q4	$630K	Sell	80,000 -50,000	-38%	-$366K	﹤0.01%	649
2015 Q3	$745K	Sell	130,000 -20,000	-13%	-$124K	﹤0.01%	643
2015 Q2	$812K	Hold	150,000	–	–	﹤0.01%	645
2015 Q1	$701K	Buy	150,000 +50,000	+50%	+$217K	﹤0.01%	675
2014 Q4	$417K	Buy	+100,000	New	+$460K	﹤0.01%	747
2014 Q3	–	Sell	-200,000	Closed	-$664K	–	887
2014 Q2	$664K	Buy	+200,000	New	+$665K	﹤0.01%	702

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GAMCO Investors's NEO Position: Q1 2026 in Review

GAMCO Investors increased its NeoGenomics (NEO) stake by 525% in Q1 2026, buying an estimated $884K and bringing the position to 100,000 shares worth $742K. The position accounts for 0.01% of the portfolio, ranked #678.

GAMCO Investors first reported a position in NEO in Q2 2014 and has held it in 36 quarters since. The position peaked at $2.94M in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

GAMCO Investors held 100,000 shares of NeoGenomics worth $742K as of Q1 2026.
GAMCO Investors bought 84,000 NeoGenomics shares in Q1 2026, an estimated $884K.
NeoGenomics made up 0.01% of GAMCO Investors's portfolio in Q1 2026, its #678 holding.
GAMCO Investors first reported a position in NeoGenomics in Q2 2014 and has held it in 36 quarters since.
GAMCO Investors's NeoGenomics position peaked at $2.94M in Q1 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.